Loading patent…
AssigneeZora Biosciences Oy
InventorsReijo Laaksonen, Kim Ekroos, Reini Hurme, Riikka Katainen
Estimating the term…
The present invention inter alia provides a method, and use thereof, of predicting severe CVD complications such as AMI or CVD death by detecting the lipid concentrations or lipid ratios of a biological sample and comparing it to a control and has identified specific lipid markers that are more specific and sensitive in predicting these CVD complications than currently utilized clinical markers. Also provided is an antibodies towards said lipids, and the use thereof for predicting, diagnosing, preventing and/or treating CVD complications. The invention additionally relates to kits comprising lipids and/or an antibody thereto, for use in the prediction and/or diagnosis of CVD complications.
A method for determining one or more lipid concentration(s), lipid-lipid concentration ratio(s) and/or lipid-clinical concentration ratio(s) in a sample by mass spectrometry (MS), comprising:
A method for treating a subject indicated as being at risk of developing one or more CVD complication(s), the method comprising:
Dependencies are inferred from the claim text.